| Clinical Neurology | Lifetime | 73 | US 33 | 99.75 |
| Medical Physiology | Lifetime | 179 | US 103 | 99.72 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 358 | US 200 | 98.92 |
| Neuroscience of Neurology | Lifetime | 442 | US 175 | 96.50 |
| Cell Biology | Lifetime | 668 | US 369 | 96.04 |
| Cellular and Molecular Neuroscience | Lifetime | 934 | US 472 | 95.24 |
| Medical Genetics | Lifetime | 689 | US 341 | 92.40 |
| Clinical Biochemistry | Lifetime | 448 | US 207 | 91.71 |
| Clinical Neurology | 2021-2025 | 32 | US 9 | 99.34 |
| Medical Physiology | 2021-2025 | 139 | US 49 | 98.36 |
| Neuroscience of Neurology | 2021-2025 | 159 | US 51 | 91.67 |
| Medical Genetics | 2021-2025 | 250 | US 112 | 86.46 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 495 | US 191 | 84.35 |
| Immunology | 2021-2025 | 973 | US 366 | 56.49 |
| Pain Mechanisms and Treatments | Lifetime | 24 | US 15 | 99.80 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 32 | US 11 | 99.67 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 23 | US 9 | 99.66 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 29 | US 8 | 99.51 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 26 | US 13 | 99.52 |
| Neuroblastoma Research and Treatments | Lifetime | 94 | US 53 | 99.17 |
| Nerve injury and regeneration | Lifetime | 99 | US 42 | 99.19 |
| Neurological and metabolic disorders | Lifetime | 39 | US 15 | 98.70 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 149 | US 68 | 98.99 |
| Adipose Tissue and Metabolism | Lifetime | 386 | US 185 | 98.98 |
| Calpain Protease Function and Regulation | Lifetime | 19 | US 10 | 98.02 |
| Advanced Glycation End Products research | Lifetime | 130 | US 46 | 97.89 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 546 | US 198 | 98.24 |
| Hereditary Neurological Disorders | Lifetime | 122 | US 43 | 97.56 |
| Metabolism, Diabetes, and Cancer | Lifetime | 617 | US 268 | 97.78 |
| Diabetic Foot Ulcer Assessment and Management | Lifetime | 309 | US 135 | 97.01 |
| Peripheral Neuropathies and Disorders | Lifetime | 345 | US 109 | 97.32 |
| Cell death mechanisms and regulation | Lifetime | 495 | US 205 | 96.64 |
| Pharmacological Effects of Natural Compounds | Lifetime | 776 | US 115 | 95.56 |
| Biochemical effects in animals | Lifetime | 939 | US 342 | 94.79 |
| Pharmacology and Obesity Treatment | Lifetime | 558 | US 237 | 94.41 |
| FOXO transcription factor regulation | Lifetime | 240 | US 113 | 89.60 |
| Lipid metabolism and disorders | Lifetime | 937 | US 317 | 91.71 |
| Peripheral Nerve Disorders | Lifetime | 818 | US 330 | 92.13 |
| Neurological diseases and metabolism | Lifetime | 896 | US 305 | 90.95 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 14 | US 3 | 98.94 |
| Adipose Tissue and Metabolism | 2021-2025 | 125 | US 33 | 96.11 |
| Pain Mechanisms and Treatments | 2021-2025 | 72 | US 22 | 97.45 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 65 | US 17 | 97.47 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 189 | US 38 | 92.93 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 542 | US 156 | 92.26 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 86 | US 30 | 89.06 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 963 | US 206 | 90.42 |
| Neurological and metabolic disorders | 2021-2025 | 117 | US 27 | 78.05 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 916 | US 179 | 75.96 |
| Regulation of Appetite and Obesity | 2021-2025 | 568 | US 177 | 74.28 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 621 | US 77 | 71.54 |
| Neurological diseases and metabolism | 2021-2025 | 452 | US 89 | 72.20 |
| Pharmacology and Obesity Treatment | 2021-2025 | 776 | US 297 | 63.52 |
| Mentoring and Academic Development | 2021-2025 | 648 | US 506 | 19.87 |
